Orgenesis Inc. - Understand $orgs stock

$ORGS Market Cap: $15.45 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$662.0K

TTM

Gross Margin

-98.05%

TTM

Net Earnings

-$37.95M

TTM

Current Assets

$2.348M

Q2 2024

Current Liabilities

$31.70M

Q2 2024

Current Ratio

7.41%

Q2 2024

Total Assets

$30.58M

Q2 2024

Total Liabilities

$46.37M

Q2 2024

Book Value

-$15.79M

Q2 2024

Cash

$77.00K

Q2 2024

P/E

-0.4071

Oct 17, 2024 EST

Free Cash Flow

-$12.54M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	$530.0K	$36.03M	$35.50M	$7.650M	$33.26M	$18.66M	$10.09M	$6.400M	$2.970M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-98.53%	1.47%	364.08%	-77.0%	78.27%	84.89%	57.66%	115.49%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue	$530.0K	$36.03M	$35.50M	$7.650M	$33.26M	$18.66M	$10.09M	$6.400M	$2.970M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$6.255M	$27.07M	$36.64M		$18.23M	$10.82M	$6.810M	$7.660M	$3.880M
Gross Profit	-$5.725M	$8.959M	-$1.142M		$15.02M	$7.831M	$3.280M	-$1.260M	-$910.0K
Gross Profit Margin	-1080.19%	24.87%	-3.22%		45.18%	41.98%	32.51%	-19.69%	-30.64%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Selling, General & Admin	$35.13M	$15.59M	$14.09M	$15.40M	$10.19M	$1.880M	$9.190M	$6.240M	$4.040M	$2.880M	$3.820M	$2.540M	$70.00K	$20.00K	$30.00K	$0.00
YoY Change	125.38%	10.63%	-8.5%	51.13%	442.02%	-79.54%	47.28%	54.46%	40.28%	-24.61%	50.39%	3528.57%	250.0%	-33.33%
% of Gross Profit		174.0%			67.82%	24.01%	280.18%
Research & Development	$10.62M	$9.169M	$36.35M	$87.06M	$12.46M	$6.464M	$2.480M	$2.160M	$1.070M	$2.620M	$1.640M	$2.450M
YoY Change	15.86%	-74.77%	-58.25%	598.83%	92.73%	160.65%	14.81%	101.87%	-59.16%	59.76%	-33.06%
% of Gross Profit		102.34%			82.92%	82.54%	75.61%
Depreciation & Amortization	$1.560M	$1.067M	$1.864M	$1.440M	$1.745M	$1.096M	$2.600M	$2.920M	$1.990M	$0.00	$0.00	$0.00
YoY Change	46.2%	-42.76%	29.44%	-17.48%	59.22%	-57.85%	-10.96%	46.73%
% of Gross Profit		11.91%			11.61%	14.0%	79.27%
Operating Expenses	$45.76M	$15.59M	$52.30M	$103.4M	$12.46M	$6.464M	$13.30M	$10.01M	$6.310M	$5.510M	$5.460M	$4.990M	$70.00K	$20.00K	$30.00K	$0.00
YoY Change	193.52%	-70.19%	-49.43%	730.23%	92.73%	-51.4%	32.87%	58.64%	14.52%	0.92%	9.42%	7028.57%	250.0%	-33.33%
Operating Profit	-$53.64M	-$8.602M	-$16.80M		-$24.60M	-$13.92M	-$10.02M	-$11.27M	-$7.220M
YoY Change	523.53%	-48.8%			76.77%	38.91%	-11.09%	56.09%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Expense	-$3.226M	-$3.479M	-$1.789M	-$1.310M	-$960.0K	-$40.00K	-$2.110M	-$1.180M	$1.820M	-$520.0K	-$40.00K	$0.00
YoY Change	-7.27%	94.47%	36.56%	36.46%	2300.0%	-98.1%	78.81%	-164.84%	-450.0%	1200.0%
% of Operating Profit
Other Income/Expense, Net	-$2.499M	-$1.971M	$2.503M	$350.0K	-$874.0K	-$3.117M	-$1.550M	-$200.0K	$30.00K	$520.0K	-$30.00K	-$10.00K
YoY Change	26.79%	-178.75%	615.14%	-140.05%	-71.96%	101.1%	675.0%	-766.67%	-94.23%	-1833.33%	200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Pretax Income	-$64.45M	-$11.96M	-$17.95M	-$96.74M	-$25.48M	-$17.77M	-$13.68M	-$12.66M	-$5.360M	-$5.500M	-$5.540M	-$5.000M	-$70.00K	-$40.00K	-$30.00K	$0.00
YoY Change	438.84%	-33.37%	-81.44%	279.7%	43.4%	29.88%	8.06%	136.19%	-2.55%	-0.72%	10.8%	7042.86%	75.0%	33.33%
Income Tax	$473.0K	$209.0K	$108.0K	-$1.610M	$563.0K	$1.337M	-$1.310M	-$1.550M	-$900.0K		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$55.36M	-$14.89M	-$18.05M	$1.110M	-$24.12M	-$18.29M	-$12.37M	-$11.11M	-$4.460M	-$5.500M	-$5.540M	-$5.000M	-$70.00K	-$40.00K	-$30.00K	$0.00
YoY Change	271.82%	-17.53%	-1726.4%	-104.6%	31.87%	47.87%	11.34%	149.1%	-18.91%	-0.72%	10.8%	7042.86%	75.0%	33.33%
Net Earnings / Revenue	-10445.47%	-41.33%	-50.85%	14.51%	-72.53%	-98.05%	-122.6%	-173.59%	-150.17%
Basic Earnings Per Share	$1.91	$0.59	$0.74		-$1.77	-$1.43
Diluted Earnings Per Share	$1.91	-$0.59	-$743.7K	$52.06K	-$1.77	-$1.43	-$1.278M	-$1.304M	-$959.1K	-$1.220M	-$1.316M	-$1.106M	-$10.43K	-$210.5K	-$157.9K	$0.00

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Cash & Short-Term Investments	$837.0K	$5.311M	$5.473M	$44.92M	$110.0K	$14.61M	$3.520M	$890.0K	$4.170M	$1.310M	$60.00K	$10.00K	$0.00	$0.00	$20.00K	$60.00K
YoY Change	-84.24%	-2.96%	-87.82%	40736.36%	-99.25%	315.06%	295.51%	-78.66%	218.32%	2083.33%	500.0%			-100.0%	-66.67%
Cash & Equivalents	$837.0K	$5.311M	$5.473M	$44.92M	$110.0K	$14.61M	$3.520M	$890.0K	$4.170M	$1.310M	$50.00K	$0.00	$0.00	$0.00	$20.00K	$60.00K
Short-Term Investments										$0.00	$10.00K	$10.00K
Other Short-Term Assets	$2.659M	$2.016M	$1.689M	$1.720M	$76.07M	$1.520M	$840.0K	$780.0K	$1.120M	$100.0K	$40.00K	$30.00K	$0.00	$0.00	$0.00	$0.00
YoY Change	31.89%	19.36%	-1.8%	-97.74%	4904.61%	80.95%	7.69%	-30.36%	1020.0%	150.0%	33.33%
Inventory	$34.00K	$120.0K	$118.0K	$190.0K	$140.0K	$1.660M	$730.0K	$400.0K	$300.0K
Prepaid Expenses
Receivables	$88.00K	$36.18M	$15.25M	$3.090M	$1.830M	$3.230M	$2.030M	$1.230M	$1.170M
Other Receivables	$458.0K	$2.688M	$3.233M	$160.0K	$210.0K	$7.040M	$180.0K	$910.0K	$1.450M
Total Short-Term Assets	$4.076M	$46.32M	$25.76M	$50.08M	$78.35M	$28.06M	$7.300M	$4.210M	$8.210M	$2.230M	$100.0K	$40.00K	$0.00	$0.00	$20.00K	$60.00K
YoY Change	-91.2%	79.82%	-48.57%	-36.08%	179.22%	284.38%	73.4%	-48.72%	268.16%	2130.0%	150.0%			-100.0%	-66.67%
Property, Plant & Equipment	$1.826M	$25.14M	$11.29M	$4.550M	$3.030M	$12.46M	$5.100M	$4.570M	$4.300M	$10.00K	$10.00K	$10.00K
YoY Change	-92.74%	122.74%	148.04%	50.17%	-75.68%	144.31%	11.6%	6.28%	42900.0%	0.0%	0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.000K	$135.0K	$152.0K	$180.0K			$1.320M	$0.00
YoY Change	-94.07%	-11.18%	-15.56%
Other Assets	$56.00K	$1.456M	$1.168M	$1.120M	$330.0K	$440.0K	$420.0K	$80.00K	$60.00K	$10.00K	$0.00	$0.00
YoY Change	-96.15%	24.66%	4.29%	239.39%	-25.0%	4.76%	425.0%	33.33%	500.0%
Total Long-Term Assets	$10.48M	$44.61M	$34.08M	$27.60M	$14.15M	$45.82M	$32.57M	$29.28M	$30.54M	$20.00K	$10.00K	$10.00K	$0.00	$0.00	$10.00K	$0.00
YoY Change	-76.52%	30.89%	23.49%	95.05%	-69.12%	40.68%	11.24%	-4.13%	152600.0%	100.0%	0.0%			-100.0%
Total Assets	$14.55M	$90.93M	$59.84M	$77.68M	$92.50M	$73.88M	$39.87M	$33.49M	$38.75M	$2.250M	$110.0K	$50.00K	$0.00	$0.00	$30.00K	$60.00K
YoY Change
Accounts Payable	$6.584M	$4.429M	$5.238M	$8.650M	$5.550M	$4.580M	$3.910M	$4.550M	$3.480M	$1.080M	$140.0K	$140.0K	$40.00K	$10.00K	$0.00	$0.00
YoY Change	48.66%	-15.44%	-39.45%	55.86%	21.18%	17.14%	-14.07%	30.75%	222.22%	671.43%	0.0%	250.0%	300.0%
Accrued Expenses	$3.513M	$4.980M	$2.873M	$2.740M	$3.640M	$4.550M	$4.400M	$2.890M	$2.160M	$1.000M	$540.0K	$150.0K	$10.00K	$0.00	$0.00	$0.00
YoY Change	-29.46%	73.34%	4.85%	-24.73%	-20.0%	3.41%	52.25%	33.8%	116.0%	85.19%	260.0%	1400.0%
Deferred Revenue
YoY Change
Short-Term Debt	$650.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$20.00K	$3.020M	$2.450M	$260.0K	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change							-100.0%	-99.34%	23.27%	842.31%
Long-Term Debt Due	$2.688M	$4.564M	$5.903M	$4.140M	$810.0K	$1.250M	$3.160M	$5.470M	$4.720M
YoY Change	-41.1%	-22.68%	42.58%	411.11%	-35.2%	-60.44%	-42.23%	15.89%
Total Short-Term Liabilities	$16.41M	$15.91M	$15.37M	$16.29M	$42.43M	$17.16M	$16.91M	$14.50M	$16.48M	$4.660M	$990.0K	$330.0K	$90.00K	$10.00K	$10.00K	$0.00
YoY Change	3.12%	3.55%	-5.68%	-61.61%	147.26%	1.48%	16.62%	-12.01%	253.65%	370.71%	200.0%	266.67%	800.0%	0.0%
Long-Term Debt	$18.97M	$13.44M	$4.895M	$7.260M	$12.14M	$3.510M	$4.530M	$4.350M	$2.540M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	41.17%	174.53%	-32.58%	-40.2%	245.87%	-22.52%	4.14%	71.26%
Other Long-Term Liabilities	$157.0K	$2.306M	$950.0K	$1.410M	$830.0K	$580.0K	$10.00K	$280.0K	$1.390M	$560.0K	$1.160M	$0.00
YoY Change	-93.19%	142.74%	-32.62%	69.88%	43.1%	5700.0%	-96.43%	-79.86%	148.21%	-51.72%
Total Long-Term Liabilities	$19.13M	$15.74M	$5.845M	$8.670M	$12.97M	$4.090M	$4.540M	$4.630M	$3.930M	$560.0K	$1.160M	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	21.49%	169.36%	-32.58%	-33.15%	217.11%	-9.91%	-1.94%	17.81%	601.79%	-51.72%
Total Liabilities	$35.54M	$63.37M	$21.35M	$25.11M	$87.02M	$47.77M	$25.75M	$20.99M	$23.73M	$5.230M	$2.150M	$330.0K	$90.00K	$10.00K	$10.00K	$0.00
YoY Change	-43.92%	196.76%	-14.96%	-71.14%	82.16%	85.51%	22.68%	-11.55%	353.73%	143.26%	551.52%	266.67%	800.0%	0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2019	2018
Basic Shares Outstanding	29.01M shares	25.10M shares	24.27M shares	15.91M shares	13.37M shares
Diluted Shares Outstanding	29.01M shares	25.10M shares		15.91M shares	13.37M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $15.448 Million

About Orgenesis Inc.

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. The company is headquartered in Germantown, Maryland and currently employs 146 full-time employees. The company went IPO on 2010-07-01. The firm focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. The company operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

Industry: Pharmaceutical Preparations Peers: Achieve Life Sciences Inc Acurx Pharmaceuticals Inc Dominari Holdings Inc BioCardia Inc Lisata Therapeutics Inc CASI Pharmaceuticals, Inc (DE) Cyclerion Therapeutics Inc Molecular Templates Inc TRACON Pharmaceuticals Inc